Soleno Therapeutics Inc’s filing revealed that its insider Yen Kristen unloaded Company’s shares for reported $0.11 million on Jan 02 ’25. In the deal valued at $45.41 per share,2,520 shares were sold. As a result of this transaction, Yen Kristen now holds 78,945 shares worth roughly $3.79 million.
Then, Yen Kristen sold 2,340 shares, generating $108,053 in total proceeds. Upon selling the shares at $46.18, the insider now owns 76,605 shares.
Before that, Mackaness James H sold 4,083 shares. Soleno Therapeutics Inc shares valued at $185,406 were divested by the CHIEF FINANCIAL OFFICER at a price of $45.41 per share. As a result of the transaction, Mackaness James H now holds 115,089 shares, worth roughly $5.53 million.
Stifel reiterated its Soleno Therapeutics Inc [SLNO] rating to a Buy in a research note published on December 02, 2024; the price target was $74. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who remained covering the stock and in early December has reiterated a ‘”an Outperform”‘ rating for it. H.C. Wainwright began covering SLNO with “Buy” recommendation on September 03, 2024. Robert W. Baird started covering the stock on May 10, 2024. It rated SLNO as “an Outperform”.
Price Performance Review of SLNO
On Friday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock fall -0.48% to $48.06. Over the last five days, the stock has gained 4.50%. Soleno Therapeutics Inc shares have risen nearly 6.92% since the year began. Nevertheless, the stocks have fallen -0.02% over the past one year. While a 52-week high of $60.92 was reached on 01/22/25, a 52-week low of $36.61 was recorded on 01/15/25. SMA at 50 days reached $49.10, while 200 days put it at $47.47.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 46.94, which if violated will result in even more drops to 45.83. On the upside, there is a resistance level at 49.47. A further resistance level may holdings at 50.89. The Relative Strength Index (RSI) on the 14-day chart is 53.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.03, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 28.23%. Stochastics %K at 73.96% indicates the stock is a holding.
How much short interest is there in Soleno Therapeutics Inc?
A steep rise in short interest was recorded in Soleno Therapeutics Inc stocks on 2024-12-31, growing by 35146.0 shares to a total of 4.59 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 4.56 million shares. There was a rise of 0.77%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 05, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $93 price target.
